Drug search by name

Conjugated estrogens and medroxyprogesterone and Retinal thrombosis

Result of checking the interaction of drug Conjugated estrogens and medroxyprogesterone and disease Retinal thrombosis for safety when used together.

Check result:

Conjugated estrogens and medroxyprogesterone <> Retinal thrombosis

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Estrogens and progestogens may cause retinal thrombosis. Oral contraceptives should be discontinued if there is unexplained partial or complete loss of vision; onset of proptosis or diplopia; papilledema; or retinal vascular lesions. Therapy with these agents should be administered cautiously in patients who have preexisting ocular problems and appropriate diagnostic and therapeutic measures should be instituted. Contact lens wearers who develop visual changes or changes in lens tolerance should be assessed by an ophthalmologist.

Conjugated estrogens and medroxyprogesterone

Generic Name: conjugated estrogens / medroxyprogesterone

Brand Name: Premphase, Prempro

Synonyms: Estrogens (Conjugated/Equine) and Medroxyprogesterone

What is Conjugated estrogens and medroxyprogesterone?